REGENERX BIOPHARMACEUTICALS INC (RGRX)
RegeneRx Biopharmaceuticals, Inc. engages in the development of a novel therapeutic peptide, Thymosin beta 4 for tissue and organ protection, repair, and regeneration. Its product pipeline includes RGN-259, RGN-352, and RGN-137. The company was founded by Allan L. Goldstein on May 13, 1982 and is headquartered in Rockville, MD.
Address
15245 SHADY GROVE ROAD
ROCKVILLE, MD 20850
Founded
1982
Number of Employees
-
Website
http://www.regenerx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at RGRX make a trade.
Creating a free account takes less than one minute